KRAS and NRAS genes mutations as biomarkers in the therapy of colorectal cancer and the basic methods of their detection

Determination of the mutations' status in the KRAS and NRAS genes is a necessary requirement in the treatment of patients with colorectal cancer (CRC). Patients with certain mutations in the KRAS and NRAS genes are resistant to anti-EGFR drug therapy and have a lower median survival rate than t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Olga I. Brovkina, Alexey G. Nikitin
Format: article
Langue:RU
Publié: Eco-vector 2021
Sujets:
R
Accès en ligne:https://doaj.org/article/f188be48a67348c79d1798ffd8d2b72d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires